What controlled substances are required to be reported in Minnesota?

In Minnesota, the prescription monitoring program requires the reporting of all controlled substances classified as C2, C3, and C4. This means that any controlled substances that fall into these categories must be reported to the state’s prescription monitoring database.

C2 substances include highly potent drugs that have a high potential for abuse and include opioids, stimulants, and certain barbiturates. C3 and C4 substances also include drugs with a lower potential for abuse compared to C2s but still require monitoring to prevent misuse and diversion.

Reporting these categories helps the state monitor prescribing patterns, identify potential cases of abuse, and support public health initiatives aimed at addressing substance use disorders. This makes the choice that includes C2, C3, and C4 prescriptions the accurate one for compliance with Minnesota regulations.

Other options, which suggest a more limited scope of reporting, do not align with the comprehensive requirements established for controlled substances in Minnesota.